[1]
C. Incorvaia, “Safety and adverse reactions in subcutaneous allergen immunotherapy: a review”, Acta Biomed, vol. 94, no. 4, p. e2023172, Aug. 2023, doi: 10.23750/abm.v94i4.14239.